$CTIC Cell Therapeutics (CTIC) Overall Average: 72% Buy. Tuesday,

Major Shareholder Notification from Morgan Stanley In accordance with the Danish Capital Markets Act, Svitzer Group A/S, recognized by CVR-no. 44 79 14 47, shares an important notification regarding its major shareholder. Morgan Stanley recently disclosed that as of a specified date, it directly or indirectly holds 1,642,654 shares in Svitzer Group. This corresponds to...

Understanding Petco Health and Wellness Legal Challenges Petco Health and Wellness Company, Inc. (NASDAQ: WOOF) has recently encountered significant legal challenges that may impact its investors. As a notable player in the pet health and wellness sector, Petco is dedicated to improving the lives of pets and their owners. However, the company is currently under scrutiny...

Survey Reveals User Preferences for AI Interaction A recent survey conducted by Muah AI has shed light on user preferences, revealing a strong inclination towards uncensored large language models (LLMs). More than 85% of the 25,000 active respondents expressed a desire for less restrictive communication tools. This finding indicates a growing demand for more open and...

Dyne Therapeutics Announces Presentations at Major Conference Dyne Therapeutics, Inc (NASDAQ: DYN), primarily known for its dedication to advancing therapeutics for neuromuscular diseases, is gearing up to showcase its innovative research at the upcoming MDA Clinical & Scientific Conference. This event is scheduled to take place from March 16-19, 2025, and will feature a...

Strengthening the Fight Against Illegal Trade Public and private sector security experts have gathered to address the escalating threat of illegal trade and its impact on American society. Over 75 leaders recently met at the USA-IT 2025 National Summit to call on Congress for new policies aimed at dismantling the $2.2 trillion underground economy, which encompasses...